Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Alphyn Biologics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Alphyn Biologics

Alphyn Biologics

Series A

Alphyn Biologics develops proprietary plant-based drug therapies for treating deadly skin diseases, including MRSA infections.

HQ
Cincinnati, OH, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Alphyn Biologics is a life science company dedicated to developing proprietary plant-based drug therapies for treating severe skin diseases, including infections caused by drug-resistant MRSA bacteria. Utilizing their Multi-Target Therapeutic (MTT) technology platform, Alphyn aims to address significant unmet medical needs in dermatology. Their market focus includes conditions like atopic dermatitis, leveraging innovative plant-derived solutions to offer effective treatments.

Alphyn Biologics has achieved significant milestones, including positive results from the second cohort of their Phase 2a clinical trial in atopic dermatitis. They have also presented interim results from their first human phase trial of Zabalafin (AB-101a) at the Masters of Pediatric Dermatology Symposium. These advancements underscore Alphyn's commitment to pioneering new therapies in dermatology, positioning them as a key player in the field of skin disease treatment.

Alphyn Biologics - Similar Companies

Alphina Therapeutics logo

Alphina Therapeutics

DermBiont logo

DermBiont

dermbiont.com

Aldena Therapeutics logo

Aldena Therapeutics

Asalyxa Bio logo

Asalyxa Bio

EpiBiologics logo

EpiBiologics

epibiologics.com

MatriSys Bioscience logo

MatriSys Bioscience

matrisysbio.com

Naked Biome logo

Naked Biome

TBT Pharma logo

TBT Pharma

tbtpharma.com

Amplifica logo

Amplifica

amplificabio.com

Alveolus Bio logo

Alveolus Bio

alveolusbio.com

Santa Ana Bio logo

Santa Ana Bio

santaanabio.com

Atavistik Bio logo

Atavistik Bio

atavistikbio.com

Arcutis Biotherapeutics logo

Arcutis Biotherapeutics

arcutis.com

Timber Pharmaceuticals logo

Timber Pharmaceuticals

Algen Biotechnologies logo

Algen Biotechnologies

algenbio.com

Alphyn Biologics - Quick Facts

Who are Alphyn Biologics' competitors?

Companies similar to Alphyn Biologics include Alphina Therapeutics, DermBiont, Aldena Therapeutics and Asalyxa Bio.

When was Alphyn Biologics founded?

Alphyn Biologics was founded in 2019.

Where is Alphyn Biologics' headquarters located?

Alphyn Biologics' headquarters is located in Cincinnati, OH, US.

When was Alphyn Biologics' last funding round?

Alphyn Biologics' most recent funding round was for $3.3M (USD) in September 2022.

How much has Alphyn Biologics raised to-date?

As of Sep 15, 2022, Alphyn Biologics has raised a total of $5.5M (USD).

How many employees does Alphyn Biologics have?

Alphyn Biologics has 2 employees as of Feb 5, 2024.

Alphyn Biologics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Therapy
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified